CNS-Aspergillosis: Are there new treatment options?

Mycoses, Supplement

Volumn 46, Issue 2, 2003, Pages 8-14

  Schwartz, S ^a,b   Thiel, E ^a,b  

^a Universitätsmedizin   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Aspergillosis; Brain abscess; CNS aspergillosis; Invasive infection

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; ASPERGILLUS; BIOAVAILABILITY; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG DISTRIBUTION; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; FEMALE; FLUCYTOSINE; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; MALE; PEPTIDES; PEPTIDES, CYCLIC; PYRIMIDINES; TRIAZOLES;

ASPERGILLUS; FUNGI;

EID: 0742304136     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Oppe (1897) Zur Kenntniss der Schimmelmykosen beim Menschen. Zbl allg Path path Anat VIII, 301-306.
2. Mukoyama, M., Gimple, K., Poser, C. M. (1969) Aspergillosis of the central nervous system: Report of a brain abscess due to A. fumigatus and review of the literature. Neurology 19, 967-974.
3. McNeil, M. M., Nash, S. L., Hajjeh, R. A. et al. (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 33, 641-647.
4. Denning, D.W. (1996) Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 23, 608-615.
5. Lin, S. J., Schranz, J., Teutsch, S. M. (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32, 358-366.
6. Herbrecht, R., Denning, D. W., Patterson, T. F. et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347, 408-415.
7. th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, USA: 126.
8. Schwartz, S., Thiel, E. (1997) Clinical presentation of invasive aspergillosis. Mycoses 40 Suppl 2, 21-24.
9. Saah, D., Drakos, P. E., Elidan, J., Braverman, I., Or, R., Nagler, A. (1994) Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann Otol Rhinol Laryngol 103, 306-310.
10. Darras-Joly, C., Veber, B., Bedos, J. P., Gachot, B., Regnier, B., Wolff, M. (1996) Nosocomial cerebral aspergillosis: a report of 3 cases. Scand J Infect Dis 28, 317-319.
11. Bodey, G., Bueltmann, B., Duguid, W. et al. (1992) Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 11, 99-109.
12. Hagensee, M. E., Bauwens, J. E., Kjos, B., Bowden, R. A. (1994) Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 19, 402-408.
13. Antunes, N. L., Hariharan, S., deAngelis, L. M. (1998) Brain abscesses in children with cancer. Med Pediatr Oncol 31, 19-21.
14. Lammens, M., Robberecht, W., Waer, M., Carton, H., Dom, R. (1992) Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus. Clin Neural Neurosurg 94, 39-43.
15. McGinnis, M. R. (1983) Detection of fungi in cerebrospinal fluid. Am J Med 75, 129-138.
16. Groll, A. H, Piscitelli, S. C., Walsh, T. J. (1998) Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol 44, 343-500.
17. Baley, J. E., Meyers, C., Kliegman, R. M., Jacobs, M. R., Blumer, J. L. (1990) Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr 116, 791-797.
18. Groll, A. H., Giri, N., Petraitis, V. et al. (2000) Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 182: 274-282.
19. Korfel, A., Menssen, H. D., Schwartz, S., Thiel, E. (1998) Cryptococcosis in Hodgkin's disease: description of two cases and review of the literature. Ann Hematol 76, 283-286.
20. Collette, N., van der Auwera, P., Pascual-Lopez, A., Heymans, C., Meunier, F. (1989) Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate. Antimicrob Agents Chemother 33, 362-368.
21. Collette, N., van der Auwera, P., Meunier, F., Lambert, C., Sculier, J. P., Coune, A. (1991) Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J Antimicrob Chemother 27, 535-548.
22. Block, E. R., Bennett, J. E. (1972) Pharmacological studies with 5-fluorocytosine. Antimicrob Agents Chemother 1, 476-482.
23. Vermes, A., Guchelaar, H. J., Dankert, J. (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46, 171-179.
24. Deresinski, S. C., Stevens, D. A. (2003) Caspofungin. Clin Infect Dis 36, 1445-1457.
25. Hajdu, R., Thompson, R., Sundelof, J. G. et al. (1997) Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743, 872). Antimicrob Agents Chemother 41, 2339-2344.
26. Perfect, J. R., Durack, D. T. (1985) Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother 16, 81-86.
27. Heykants, J., Michiels, M., Meuldermans, W. et al. (1987) The pharmacokinetics of itraconazole in animals and man: an overview. In: Fromtling, R. A. (ed) Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona: J. R. Prous Science Publishers, pp. 223-249.
28. Verweij, P. E., Brinkman, K., Kremer, H. P., Kullberg, B. J., Meis, J. F. (1999) Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 37, 1186-1189.
29. Muijsers, R. B., Goa, K. L., Scott, L. J. (2002) Voriconazole in the treatment of invasive aspergillosis. Drugs 62, 2655-2664.
30. Schwartz, S., Milatovic, D., Thiel, E. (1997) Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 97, 663-665.
31. th, June 2002 at: International Workshop on Voriconazole. Dublin, Ireland.
32. Coleman, J. M., Hogg, G. G., Rosenfeld, J. V., Waters, K. D. (1995) Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery - case report and review of the literature. Neurosurgery 36, 858-863.
33. Baslar, Z., Soysal, T., Hanci, M. et al. (1997) Successful outcome of Aspergillus brain abscess in a patient who underwent bone marrow transplantation for aplastic anemia. Haematologia 28, 265-271.
34. Carlini, A., Angelini, D., Burrows, L., de Quirico, G., Antonelli, A. (1998) Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant. Nephrol Dial Transplant 13, 2659-2661.
35. Erdogan, E., Beyzadeoglu, M., Arpaci, F., Celasun, B. (2002) Cerebellar aspergillosis: case report and literature review. Neurosurgery 50, 874-876.
36. Garcia, A., Mazuecos, A., Clavo, A. et al. (1998) Isolated cerebral aspergillosis without a portal of entry - complete recovery after liposomal amphotericin B and surgical treatment. Nephrol Dial Transplant 13, 2385-2387.
37. Gaubitz, M., Moskopp, D., Fegeler, W, Hilker, E., Domschke, W. (2000) Cerebral aspergillosis in systemic lupus erythematosus. J Rheumatol 27, 2518-2519.
38. Iemmolo, R. M., Rossanese, A., Rotilio, A. et al. (1998) Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery. J Hepatol 28, 518-522.
39. Imai, T., Yamamoto, T., Tanaka, S. et al. (1999) Successful treatment of cerebral aspergillosis with a high oral dose of itraconazole after excisional surgery. Intern Med 38, 829-832.
40. Khoury, H., Adkins, D., Miller, G., Goodnough, L., Brown, R., diPersio, J. (1997) Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant 20, 179-180.
41. Mahlknecht, U., von Lintig, F., Mertelsmann, R., Lindemann, A., Lübbert, M. (1997) Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia. Leuk Lymphoma 27, 191-194.
42. Mikolich, D. J., Kinsella, L. J., Skowron, G., Friedman, J., Sugar, A. M. (1996) Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin Infect Dis 23, 1318-1319.
43. Moling, O., Lass-Floerl, C., Verweij, P. E. et al. (2002) Case Reports. Chronic and acute Aspergillus meningitis. Mycoses 45, 504-511.
44. Ng, A., Gadong, N., Kelsey, A., Denning, D. W., Leggate, J., Eden, O. B. (2000) Successful treatment of Aspergillus brain abscess in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 17, 497-504.
45. Sanchez, C., Mauri, E., Dalmau, D., Quintana, S., Aparicio, A., Garau, J. (1995) Treatment of cerebral aspergillosis with itraconazole: do high doses improve the prognosis? Clin Infect Dis 21, 1485-1487.
46. Saulsbury, F. T. (2001) Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 32, e137-139.
47. th European Congress of Clinical Microbiology and Infectious Diseases. Milan, Italy.
48. Machetti, M., Zotti, M., Veroni, L. et al. (2000) Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis 2, 140-144.
49. Ascioglu, S., Rex, J. H., de Pauw, B. et al. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34, 7-14.
50. Denning, D. W., Ribaud, P., Milpied, N. et al. (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34, 563-571.
51. Walsh, T. J., Lutsar, I., Driscoll, T. et al. (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21, 240-248.
52. Perfect, J. R., Marr, K. A., Walsh, T. J. et al. (2003) Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 36, 1122-1131.
53. Verweij, P. E., Donnelly, J. P., Meis, J. F. (1996) High-dose itraconazole for the treatment of cerebral aspergillosis. Clin Infect Dis 23, 1196-1197.